Regarding anticholinergic effects on skeletal muscle, which statement is accurate?

Regarding anticholinergic effects on skeletal muscle, which statement is accurate?

• A. NOTHING since Post-Ganglionic Receptors are for Epinephrine and Norepinephrine
• B. Increased acetylcholine release
• C. Fasciculations
• D. Muscle weakness

Answer: (A)

Anticholinergic drugs block muscarinic receptors in parasympathetic tissues, not the nicotinic receptors at the skeletal muscle neuromuscular junction. Skeletal muscle contraction is triggered when acetylcholine binds to nicotinic receptors on the muscle fiber, a site that anticholinergics do not block. Because their action is limited to muscarinic sites, there is no direct effect on skeletal muscle function, so the idea that nothing happens at the muscle level is the most accurate interpretation. In contrast, changes like increased acetylcholine release or fasciculations would involve altered transmission at the neuromuscular junction or cholinergic excess, which isn’t caused by muscarinic blockade. Muscle weakness would similarly imply disruption of NMJ nicotinic transmission or broader neuromuscular issues, not just muscarinic antagonism. The key point is that anticholinergic effects mainly alter autonomic (parsympathetic) signaling, not skeletal muscle contraction.

Anticholinergic drugs block muscarinic receptors in parasympathetic tissues, not the nicotinic receptors at the skeletal muscle neuromuscular junction. Skeletal muscle contraction is triggered when acetylcholine binds to nicotinic receptors on the muscle fiber, a site that anticholinergics do not block. Because their action is limited to muscarinic sites, there is no direct effect on skeletal muscle function, so the idea that nothing happens at the muscle level is the most accurate interpretation.

In contrast, changes like increased acetylcholine release or fasciculations would involve altered transmission at the neuromuscular junction or cholinergic excess, which isn’t caused by muscarinic blockade. Muscle weakness would similarly imply disruption of NMJ nicotinic transmission or broader neuromuscular issues, not just muscarinic antagonism. The key point is that anticholinergic effects mainly alter autonomic (parsympathetic) signaling, not skeletal muscle contraction.